Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score? Reply to Adams and Kwee

Mark J Bishton; Andrew K McMillan; Christopher P Fox

doi:10.1111/bjh.14050

Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score? Reply to Adams and Kwee

Br J Haematol. 2017 Apr;177(2):320-321. doi: 10.1111/bjh.14050. Epub 2016 Mar 28.

Authors

Mark J Bishton¹, Andrew K McMillan¹, Christopher P Fox¹

Affiliation

¹ Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.

PMID: 27018322
DOI: 10.1111/bjh.14050

No abstract available

Keywords: National Comprehensive Cancer Network International Prognostic Index; diffuse large B cell lymphoma; positron emission tomography; prognostic factors.

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Fluorodeoxyglucose F18*
Humans
Lymphoma, Large B-Cell, Diffuse
Positron-Emission Tomography*
Prognosis
Retrospective Studies

Substances

Fluorodeoxyglucose F18